Free Trial

Solid Biosciences (SLDB) Short Interest Ratio & Short Volume

Solid Biosciences logo
$5.78 -0.22 (-3.67%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$6.11 +0.33 (+5.71%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solid Biosciences Short Interest Data

Solid Biosciences (SLDB) has a short interest of 2.65 million shares, representing 8.09% of the float (the number of shares available for trading by the public). This marks a 13.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.2, indicating that it would take 5.2 days of the average trading volume of 5.25 million shares to cover all short positions.

Current Short Interest
2,650,000 shares
Previous Short Interest
2,330,000 shares
Change Vs. Previous Month
+13.73%
Dollar Volume Sold Short
$8.43 million
Short Interest Ratio
5.2 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
40,580,000 shares
Float Size
32,740,000 shares
Short Percent of Float
8.09%
Today's Trading Volume
2,182,549 shares
Average Trading Volume
5,248,189 shares
Today's Volume Vs. Average
42%
Short Selling Solid Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Solid Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SLDB Short Interest Over Time

SLDB Days to Cover Over Time

SLDB Percentage of Float Shorted Over Time

Solid Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20252,650,000 shares $8.43 million +13.7%8.1%5.2 $3.18
1/15/20252,330,000 shares $7.32 million +13.1%7.1%5.7 $3.14
12/31/20242,060,000 shares $8.24 million +17.1%6.3%5.3 $4.00
12/15/20241,760,000 shares $8.64 million +13.6%5.4%5.6 $4.91
11/30/20241,550,000 shares $8.84 million +2.0%4.8%5.3 $5.70
11/15/20241,520,000 shares $7.37 million +2.7%4.7%5.3 $4.85
10/31/20241,480,000 shares $8.17 million -16.4%4.4%5.5 $5.52
10/15/20241,770,000 shares $11.74 million +2.3%5.5%6.6 $6.63
9/30/20241,730,000 shares $12.06 million +4.2%5.3%6 $6.97
9/15/20241,660,000 shares $13.16 million -1.8%5.1%3.9 $7.93
8/31/20241,690,000 shares $15.09 million -2.3%5.2%3.6 $8.93
8/15/20241,730,000 shares $15.45 million +8.1%5.3%3.6 $8.93
7/31/20241,600,000 shares $14.27 million -3.6%5.0%3.6 $8.92
7/15/20241,660,000 shares $14.21 million -45.6%5.2%3.7 $8.56
6/30/20243,050,000 shares $17.29 million +237.4%9.6%7.8 $5.67
6/15/2024904,100 shares $7.14 million +7.6%2.8%3.1 $7.90
5/31/2024840,200 shares $6.94 million -9.6%2.7%3.4 $8.26
5/15/2024929,200 shares $9.00 million +1.7%3.0%3.8 $9.69
4/30/2024913,600 shares $8.10 million -13.0%3.0%3.6 $8.87
4/15/20241,050,000 shares $10.50 million +14.0%3.5%4 $10.00
3/31/2024920,900 shares $12.27 million +49.8%3.1%2.5 $13.32
3/15/2024614,900 shares $8.04 million -3.0%2.0%1.8 $13.08
2/29/2024633,600 shares $5.95 million +4.3%2.1%1.3 $9.39
2/15/2024607,300 shares $5.97 million +41.8%2.0%1.3 $9.83
1/31/2024428,300 shares $2.95 million +11.5%1.8%0.6 $6.89
1/15/2024384,000 shares $2.96 million +55.0%2.8%0.6 $7.71
12/31/2023247,800 shares $1.52 million +21.8%1.5%0.4 $6.14
12/15/2023203,400 shares $1.06 million -6.4%1.2%0.4 $5.19
11/30/2023217,200 shares $612,504.00 +508.4%1.3%0.5 $2.82
11/15/202335,700 shares $97,282.50 -5.8%0.2%0.1 $2.73
10/31/202337,900 shares $84,517.00 +76.3%0.2%1.4 $2.23
10/15/202321,500 shares $46,440.00 -27.4%0.1%0.9 $2.16
9/30/202329,600 shares $74,592.00 -0.3%0.2%2 $2.52
9/15/202329,700 shares $92,664.00 -1.3%0.2%2.3 $3.12
8/31/202330,100 shares $108,661.00 -30.0%0.2%1.4 $3.61
8/15/202343,000 shares $161,465.00 +24.6%0.3%2.1 $3.76
7/31/202334,500 shares $148,695.00 -20.0%0.2%1.6 $4.31
7/15/202343,100 shares $211,625.31 -1.4%0.3%1.7 $4.91
6/30/202343,700 shares $228,988.00 +7.1%0.3%1.6 $5.24
6/15/202340,800 shares $255,408.00 +60.0%0.3%1.3 $6.26
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

5/31/202325,500 shares $157,590.00 -37.4%0.2%0.8 $6.18
5/15/202340,700 shares $254,375.00 +5.4%0.3%1.2 $6.25
4/30/202338,600 shares $188,368.00 -14.2%0.3%1.1 $4.88
4/15/202345,000 shares $228,150.00 +24.7%0.3%1.2 $5.07
3/31/202336,100 shares $171,114.00 +71.9%0.2%1 $4.74
3/15/202321,000 shares $100,800.00 +62.8%0.1%0.6 $4.80
2/28/202312,900 shares $72,498.00 -6.5%0.1%0.5 $5.62
2/15/202313,800 shares $92,598.00 -85.2%0.1%0.5 $6.71
1/31/202393,200 shares $706,456.00 +162.5%1.0%3.3 $7.58
1/15/202335,500 shares $239,625.00 -36.2%0.4%1.1 $6.75
12/30/202255,600 shares $299,128.00 -27.8%0.6%1.8 $5.38
12/15/202277,000 shares $527,450.00 -21.5%2.1%2.3 $6.85
11/30/202298,100 shares $657,270.00 -11.1%1.6%3.1 $6.70
11/15/2022110,400 shares $734,160.00 +69.1%1.8%3.7 $6.65
10/31/202265,300 shares $418,573.00 -91.3%1.0%2 $6.41
10/15/2022749,700 shares $342,088.11 +10.7%0.8%1.9 $0.46
9/30/2022677,300 shares $316,028.18 -2.6%0.8%1.7 $0.47
9/15/2022695,500 shares $443,311.70 +59.8%0.8%1.3 $0.64
8/31/2022435,200 shares $278,528.00 -17.2%0.5%0.7 $0.64
8/15/2022525,600 shares $435,617.28 +14.7%0.6%0.8 $0.83
7/31/2022458,400 shares $309,420.00 -27.0%0.5%0.7 $0.68
7/15/2022628,100 shares $425,223.70 -89.8%0.7%0.8 $0.68
6/30/20226,180,000 shares $3.80 million -25.5%7.3%7.9 $0.62
6/15/20228,290,000 shares $4.93 million No Change9.7%11 $0.59
5/31/20228,290,000 shares $4.73 million -0.5%9.7%10.2 $0.57
5/15/20228,330,000 shares $4.20 million +1.7%9.8%10.7 $0.50
4/30/20228,190,000 shares $4.59 million +15.2%9.4%9.9 $0.56
4/15/20227,110,000 shares $7.47 million -6.1%8.4%7.8 $1.05
3/31/20227,570,000 shares $9.08 million -1.3%8.9%6.9 $1.20
3/15/20227,670,000 shares $7.56 million +14.0%9.0%6.9 $0.99
2/28/20226,730,000 shares $5.48 million +1.2%7.9%5.7 $0.82
2/15/20226,650,000 shares $7.18 million -6.7%7.9%4.7 $1.08
1/31/20227,130,000 shares $8.70 million +4.9%8.5%4.5 $1.22
1/15/20226,800,000 shares $9.52 million +8.8%10.5%4.3 $1.40
12/31/20216,250,000 shares $10.94 million +1.3%9.7%4.3 $1.75
12/15/20216,170,000 shares $11.41 million No Change9.6%4.1 $1.85
11/30/20216,170,000 shares $10.80 million -6.5%9.6%3.5 $1.75
11/15/20216,600,000 shares $14.32 million -4.4%10.2%4.9 $2.17
10/29/20216,900,000 shares $14.01 million -2.4%10.7%6 $2.03
10/15/20217,070,000 shares $15.91 million +1.1%10.9%7.1 $2.25
9/30/20216,990,000 shares $16.71 million +9.6%10.8%7.5 $2.39
9/15/20216,380,000 shares $16.78 million -2.6%9.9%6.8 $2.63
8/31/20216,550,000 shares $17.75 million -5.1%10.1%10.7 $2.71
8/13/20216,900,000 shares $18.35 million +0.7%10.7%9 $2.66
7/30/20216,850,000 shares $19.11 million +14.7%10.6%7.6 $2.79
7/15/20215,970,000 shares $18.03 million -10.2%9.2%6.6 $3.02
6/30/20216,650,000 shares $24.34 million +10.3%10.3%7.3 $3.66
6/15/20216,030,000 shares $24.30 million +3.6%9.3%5.9 $4.03
5/28/20215,820,000 shares $22.12 million No Change9.0%3.9 $3.80
5/14/20215,820,000 shares $25.84 million +3.4%N/A3.7 $4.44
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

4/30/20215,630,000 shares $29.16 million +0.9%N/A3.5 $5.18
4/15/20215,580,000 shares $29.57 million -1.1%N/A3.4 $5.30
3/31/20215,640,000 shares $30.68 million +67.4%N/A3.2 $5.44
3/15/20213,370,000 shares $32.08 million +22.6%N/A2 $9.52
2/26/20212,750,000 shares $22.03 million +23.9%N/A1.3 $8.01
2/12/20212,220,000 shares $17.58 million +4.7%N/A1.1 $7.92
1/29/20212,120,000 shares $13.50 million +2.9%N/A1.2 $6.37
1/15/20212,060,000 shares $13.31 million +0.5%N/A1 $6.46
12/31/20202,050,000 shares $15.97 million -16.3%N/A1.1 $7.79
12/15/20202,450,000 shares $11.74 million -23.7%N/A0.5 $4.79
11/30/20203,210,000 shares $10.21 million No Change10.8%0.8 $3.18
11/15/20203,210,000 shares $10.18 million -1.2%10.8%0.8 $3.17
10/30/20203,250,000 shares $11.08 million -11.4%14.3%0.8 $3.41
10/15/20203,670,000 shares $14.50 million +164.0%12.0%0.9 $3.95
9/30/20201,390,000 shares $2.82 million -11.5%4.5%0.4 $2.03
9/15/20201,570,000 shares $3.89 million -5.4%5.1%7.2 $2.48
8/31/20201,660,000 shares $3.97 million -8.8%5.4%6.7 $2.39
8/14/20201,820,000 shares $4.99 million -12.5%6.0%6.3 $2.74
7/31/20202,080,000 shares $5.47 million -8.8%7.2%6.4 $2.63
7/15/20202,280,000 shares $6.52 million +0.9%7.9%6.7 $2.86
6/30/20202,260,000 shares $7.03 million +12.4%7.8%6.8 $3.11
6/15/20202,010,000 shares $6.05 million +20.4%7.0%6.3 $3.01
5/29/20201,670,000 shares $5.06 million +28.5%5.7%4.7 $3.03
5/15/20201,300,000 shares $3.71 million +63.4%4.5%3.7 $2.85
4/30/2020795,600 shares $1.98 million -18.7%2.7%2.5 $2.49
4/15/2020978,800 shares $2.44 million -7.7%3.4%3.1 $2.49
3/31/20201,060,000 shares $2.39 million -51.8%3.6%2.6 $2.25
3/13/20202,197,600 shares $5.38 million -24.2%7.5%5.1 $2.45
2/28/20202,900,000 shares $6.76 million +0.7%9.9%3.3 $2.33

SLDB Short Interest - Frequently Asked Questions

What is Solid Biosciences' current short interest?

Short interest is the volume of Solid Biosciences shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 2,650,000 shares of SLDB short. 8.09% of Solid Biosciences' shares are currently sold short. Learn More on Solid Biosciences' current short interest.

What is a good short interest ratio for Solid Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLDB shares currently have a short interest ratio of 5.0. Learn More on Solid Biosciences's short interest ratio.

Which institutional investors are shorting Solid Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Solid Biosciences: Group One Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Solid Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.09% of Solid Biosciences' floating shares are currently sold short.

Is Solid Biosciences' short interest increasing or decreasing?

Solid Biosciences saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 2,650,000 shares, an increase of 13.7% from the previous total of 2,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Solid Biosciences' float size?

Solid Biosciences currently has issued a total of 40,580,000 shares. Some of Solid Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Solid Biosciences currently has a public float of 32,740,000 shares.

How does Solid Biosciences' short interest compare to its competitors?

8.09% of Solid Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Solid Biosciences: Kura Oncology, Inc. (12.39%), CorMedix Inc. (11.83%), Arbutus Biopharma Co. (3.55%), Pharming Group (0.01%), Immatics (8.39%), ORIC Pharmaceuticals, Inc. (14.71%), Rapport Therapeutics (8.64%), Precigen, Inc. (11.70%), Stoke Therapeutics, Inc. (16.97%), Cullinan Therapeutics, Inc. (23.70%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Solid Biosciences stock?

Short selling SLDB is an investing strategy that aims to generate trading profit from Solid Biosciences as its price is falling. SLDB shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Solid Biosciences?

A short squeeze for Solid Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLDB, which in turn drives the price of the stock up even further.

How often is Solid Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLDB, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:SLDB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners